NYSE
SCE-PN
Last Price
US $22.97
Valuation
Financial
Performance
Cash flow to debt coverage
SCE Trust VIII balance-sheet data unavailable; cash-flow debt coverage cannot be computed.
Free cash flow growth
SCE Trust VIII has insufficient data to evaluate this check.
Debt-to-equity ratio
SCE Trust VIII has insufficient data to evaluate this check.
Debt-to-equity trend
SCE Trust VIII has insufficient data to evaluate this check.
Net debt to EBITDA
SCE Trust VIII has negative EBITDA, making leverage ratio unreliable
Interest coverage
SCE Trust VIII interest expense data unavailable for the most recent period; interest coverage ratio cannot be reliably computed.
Profit margin growth
SCE Trust VIII has insufficient data to evaluate this check.
Current ratio
SCE Trust VIII has insufficient data to evaluate this check.
Return on assets
SCE Trust VIII's return on assets of 0.00% is lower than the 5.00% threshold, indicating inefficient asset utilization
Return on equity
SCE Trust VIII's return on equity of 0.00%, is lower than 15.00%, indicating bad performance
Earnings quality
SCE Trust VIII has insufficient data to evaluate this check.
Earnings stability
SCE Trust VIII has insufficient public price history to evaluate earnings stability.
Positive free cash flow
SCE Trust VIII has negative free cash flow, indicating the company is burning cash rather than generating it
Free cash flow yield
SCE Trust VIII has a free cash flow yield of 0.00%, which is below the 2.00% threshold, indicating limited cash return relative to market value
Earnings growth
SCE Trust VIII has insufficient data to evaluate this check.
Revenue growth
SCE Trust VIII has insufficient data to evaluate this check.
Return on invested capital
ROIC is unavailable for SCE Trust VIII; this check cannot be evaluated.
3-year revenue CAGR
SCE Trust VIII has insufficient revenue history to calculate 3-year revenue CAGR.
Revenue consistency
SCE Trust VIII has insufficient public price history to evaluate revenue consistency.
Return on equity consistency
SCE Trust VIII has insufficient public price history to evaluate ROE consistency.
Cash Flow Valuation (DCF)
SCE Trust VIII has insufficient data to evaluate this check.
Earnings yield (TTM)
SCE Trust VIII has insufficient data to evaluate this check.
EBITDA Valuation
SCE Trust VIII is overvalued relative to its fair value price of 0.00 based on EBITDA multiple model
EV/EBITDA (FY)
SCE Trust VIII has negative or missing EBITDA, making EV/EBITDA ratio unreliable
PEG ratio (TTM/FY)
SCE Trust VIII has insufficient data to calculate the PEG ratio.
Price-to-book ratio (FY)
SCE Trust VIII has negative shareholder equity; price-to-book is not meaningful and the check fails
Price-to-sales ratio (TTM)
SCE Trust VIII has a price-to-sales ratio of 999.00x, which exceeds the 8.00x threshold, indicating the stock may be overvalued relative to its revenue
Profit margin
Current Ratio
Capital Returns
Valuation History
Cash flow
Profit margin
Fair Value
Market $22.97
—
Default assumptions
Base valuations use default assumptions. Customize in the Valuator.